Show simple item record

dc.contributor.authorBeyer, Katharina
dc.contributor.authorMoris, Lisa
dc.contributor.authorLardas, Michael
dc.contributor.authorHaire, Anna
dc.contributor.authorBarletta, Francesco
dc.contributor.authorScuderi, Simone
dc.contributor.authorVradi, Eleni
dc.contributor.authorGandaglia, Giorgio
dc.contributor.authorOmar, Muhammad Imran
dc.contributor.authorMacLennan, Steven
dc.contributor.authorZong, Jihong
dc.contributor.authorFarahmand, Bahman
dc.contributor.authorMacLennan, Sara J.
dc.contributor.authorDevecseri, Zsuzsanna
dc.contributor.authorAsiimwe, Alex
dc.contributor.authorCollette, Laurence
dc.contributor.authorBjartell, Anders
dc.contributor.authorN'Dow, James
dc.contributor.authorBriganti, Alberto
dc.contributor.authorVan Hemelrijck, Mieke
dc.contributor.authorThe PIONEER Consortium
dc.date.accessioned2021-02-25T15:01:01Z
dc.date.available2021-02-25T15:01:01Z
dc.date.issued2021
dc.identifier.citationBeyer , K , Moris , L , Lardas , M , Haire , A , Barletta , F , Scuderi , S , Vradi , E , Gandaglia , G , Omar , M I , MacLennan , S , Zong , J , Farahmand , B , MacLennan , S J , Devecseri , Z , Asiimwe , A , Collette , L , Bjartell , A , N'Dow , J , Briganti , A , Van Hemelrijck , M & The PIONEER Consortium 2021 , ' Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol ' , BMJ Open , vol. 11 , no. 2 , e040531 . https://doi.org/10.1136/bmjopen-2020-040531en
dc.identifier.issn2044-6055
dc.identifier.otherPURE: 178728831
dc.identifier.otherPURE UUID: b063cbdb-5944-4fb6-ae2e-5d8489537e79
dc.identifier.otherPubMed: 33574142
dc.identifier.otherORCID: /0000-0002-2691-8421/work/90172341
dc.identifier.otherORCID: /0000-0002-1597-3126/work/90172594
dc.identifier.otherORCID: /0000-0003-1405-6964/work/90173328
dc.identifier.otherScopus: 85100831811
dc.identifier.otherWOS: 000620630800027
dc.identifier.urihttps://hdl.handle.net/2164/15928
dc.descriptionFunding PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).en
dc.format.extent5
dc.language.isoeng
dc.relation.ispartofBMJ Openen
dc.rights© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.en
dc.subjectProstate canceren
dc.subjectdiagnostic factoren
dc.subjectprognostic factorsen
dc.subjectUrological tumoursen
dc.subjectProstate diseaseen
dc.subjectOncologyen
dc.subjectBIASen
dc.subjectRISKen
dc.subjectoncologyen
dc.subjectPROBASTen
dc.subjectAPPLICABILITYen
dc.subjecturological tumoursen
dc.subjectTOOLen
dc.subjectprostate diseaseen
dc.subjectR Medicine (General)en
dc.subjectMedicine(all)en
dc.subject.lccR1en
dc.titleDiagnostic and prognostic factors in patients with prostate cancer: a systematic review protocolen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.contributor.institutionUniversity of Aberdeen.Academic Urology Uniten
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2020-040531
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85100831811&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record